Notices. Notice

7,590 words·~35 min read·/register/2006/06/09/06-5134

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE 6560-50-S ENVIRONMENTAL PROTECTION AGENCY [EPA-HQ-OPP-2005-0061; FRL-8072-9] Azinphos-methyl and Phosmet Proposed Decisions; Notice of Availability AGENCY: Environmental Protection Agency (EPA). ACTION: Notice. SUMMARY: This notice announces the availability of EPA's proposed re-evaluation decisions for the pesticides azinphos-methyl and phosmet, the grower impact assessments, human health documents, environmental fate and effects documents, and other related documents, and opens a 60-day public comment period.

These proposed decisions implement the 2001 IREDs for these pesticides as well as the 2001 Memorandum of Agreement between EPA and the phosmet technical registrants and the 2002 Memorandum of Agreement between EPA and the azinphos-methyl technical registrants. EPA is proposing a schedule to phase out the remaining uses of azinphos-methyl and is proposing to lengthen some restricted-entry intervals

(REIs)and seek additional biomonitoring data for the nine time-limited uses of phosmet. EPA is also proposing certain additional restrictions on the use of azinphos-methyl and phosmet. DATES: Comments must be received on or before August 8, 2006. ADDRESSES: Submit your comments, identified by docket identification

(ID)number EPA-HQ-OPP-2005-0061 for azinphos-methyl, or identified by docket identification

(ID)number EPA-HQ-OPP-2002-0354 for phosmet, by one of the following methods: • Federal eRulemaking Portal: *http://www.regulations.gov* . Follow the on-line instructions for submitting comments. • *Mail* : Office of Pesticide Programs

(OPP)Regulatory Public Docket (7502P), Environmental Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460-0001. • *Delivery* : OPP Regulatory Public Docket (7502P), Environmental Protection Agency, Rm. S-4400, One Potomac Yard (South Building), 2777 S. Crystal Drive, Arlington, VA. Deliveries are only accepted during the Docket's normal hours of operation (8:30 a.m. to 4 p.m., Monday through Friday, excluding legal holidays). Special arrangements should be made for deliveries of boxed information. The Docket telephone number is

(703)305-5805. *Instructions* : Direct your comments to docket ID number EPA-HQ-OPP-2005-0061 for azinphos-methyl and to docket ID number EPA-HQ-OPP-2002-0354 for phosmet. EPA's policy is that all comments received will be included in the docket without change and may be made available on-line at *http://www.regulations.gov* , including any personal information provided, unless the comment includes information claimed to be Confidential Business Information

(CBI)or other information whose disclosure is restricted by statute. Do not submit information that you consider to be CBI or otherwise protected through regulations.gov or e-mail. The Federal regulations.gov website is an “anonymous access” system, which means EPA will not know your identity or contact information unless you provide it in the body of your comment. If you send an e-mail comment directly to EPA without going through regulations.gov, your e-mail address will be automatically captured and included as part of the comment that is placed in the docket and made available on the Internet. If you submit an electronic comment, EPA recommends that you include your name and other contact information in the body of your comment and with any disk or CD-ROM you submit. If EPA cannot read your comment due to technical difficulties and cannot contact you for clarification, EPA may not be able to consider your comment. Electronic files should avoid the use of special characters, any form of encryption, and be free of any defects or viruses. *Docket* : All documents in the docket are listed in the docket index. Although listed in the index, some information is not publicly available, e.g., CBI or other information whose disclosure is restricted by statute. Certain other material, such as copyrighted material, is not placed on the Internet and will be publicly available only in hard copy form. Publicly available docket materials are available either in the electronic docket at *http://www.regulations.gov* , or, if only available in hard copy, at the OPP Regulatory Public Docket in Rm. S-4400, One Potomac Yard (South Building), 2777 S. Crystal Drive, Arlington, VA. The hours of operation of this Docket Facility are from 8:30 a.m. to 4 p.m., Monday through Friday, excluding legal holidays. The Docket telephone number is

(703)305-5805. FOR FURTHER INFORMATION CONTACT: Tom Myers, Special Review and Reregistration Division (7508P), Office of Pesticide Programs, Environmental Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460-0001; telephone number: 703-308-8589, fax number: 703-308-8041; e-mail address: *myers.tom@epa.gov* . SUPPLEMENTARY INFORMATION: I. General Information A. Does this Action Apply to Me? This action is directed to the public in general, and may be of interest to a wide range of stakeholders including environmental, human health, farmworker, and agricultural advocates; the chemical industry; pesticide users; and members of the public interested in the sale, distribution, or use of pesticides. Since others also may be interested, the Agency has not attempted to describe all the specific entities that may be affected by this action. If you have any questions regarding the applicability of this action to a particular entity, consult the person listed under FOR FURTHER INFORMATION CONTACT . B. What Should I Consider as I Prepare My Comments for EPA? 1. *Submitting CBI* . Do not submit this information to EPA through regulations.gov or e-mail. Clearly mark the part or all of the information that you claim to be CBI. For CBI information in a disk or CD ROM that you mail to EPA, mark the outside of the disk or CD ROM as CBI and then identify electronically within the disk or CD ROM the specific information that is claimed as CBI. In addition to one complete version of the comment that includes information claimed as CBI, a copy of the comment that does not contain the information claimed as CBI must be submitted for inclusion in the public docket. Information so marked will not be disclosed except in accordance with procedures set forth in 40 CFR part 2. 2. *Tips for preparing your comments* . When submitting comments, remember to: i. Identify the document by docket ID number and other identifying information (subject heading, **Federal Register** date and page number). ii. Follow directions. The Agency may ask you to respond to specific questions or organize comments by referencing a Code of Federal Regulations

(CFR)part or section number. iii. Explain why you agree or disagree; suggest alternatives and substitute language for your requested changes. iv. Describe any assumptions and provide any technical information and/or data that you used. v. If you estimate potential costs or burdens, explain how you arrived at your estimate in sufficient detail to allow for it to be reproduced. vi. Provide specific examples to illustrate your concerns and suggest alternatives. vii. Explain your views as clearly as possible, avoiding the use of profanity or personal threats. viii. Make sure to submit your comments by the comment period deadline identified. II. Background A. What Action is the Agency Taking? EPA is making available the proposed decision documents and related supporting documents for azinphos-methyl and phosmet. In the azinphos-methyl 2001 IRED, and subsequent Memorandum of Agreement, the Agency concluded, based on evaluation of the risks and benefits of the use of azinphos-methyl, that 35 uses should either be immediately canceled or phased out over a four-year period. The remaining ten time-limited azinphos-methyl uses (almonds, apples/crabapples, highbush and lowbush blueberries, Brussels sprouts, cherries, nursery stock, parsley, pears, pistachios, and walnuts) were eligible for reregistration for a period of four years, after which EPA would accept and evaluate applications for renewal of the registrations. In the phosmet 2001 IRED EPA determined that three uses should be canceled and that 33 uses were eligible for reregistration. EPA made a time-limited determination for nine uses (apples, crabapples, peaches, pears, nectarines, apricots, plums/prunes, grapes, and highbush blueberries) and would reconsider those uses in 2006. The IRED provided that this reconsideration would involve a determination whether the restricted-entry intervals

(REIs)for workers that were imposed as a result of the IRED should be maintained indefinitely or whether longer “default” REIs, or other appropriate REIs, should be adopted. These IREDs were implemented through Memoranda of Agreements with the phosmet and azinphos-methyl technical registrants in 2001 and 2002, respectively. After consideration of the risks and benefits of these pesticides, as provided in the IREDs, EPA is proposing that the remaining uses of azinphos-methyl be phased out according to the following schedule: almonds, pistachios, walnuts, Brussels sprouts, and nursery stock in 2007 and apples/crabapples, blueberries, cherries, pears, and parsley in 2010. EPA is also proposing certain additional risk-mitigation restrictions and activities, including larger buffers, reducing annual application rates, and eliminating the few remaining aerial uses. EPA is proposing to increase the REIs for most of the nine time-limited uses of phosmet and to require additional biomonitoring data and additional use restrictions. The decision documents, including the Agency's supporting rationale for these proposed decisions can be found in docket identification number EPA-HQ-OPP-2005-0061 for azinphos-methyl, and docket identification number EPA-HQ-OPP-2002-0354 for phosmet at *http://www.regulations.gov* . EPA is providing an opportunity, through this notice, for interested parties to provide comments and input on the Agency's proposed decisions for azinphos-methyl and phosmet. Comments should be limited to issues raised by the proposed decisions and associated documents. All comments should be submitted using the methods in ADDRESSES, and must be received by EPA on or before the closing date. Comments will become part of the Agency Docket for azinphos-methyl and phosmet. B. What is the Agency's Authority for Taking this Action? EPA is reevaluating these uses of AZM and phosmet pursuant to section 3c(5) of FIFRA, which provides, among other things, that the EPA Adminstrator shall register a pesticide when its use will not cause unreasonable adverse effects on the environment. List of Subjects Environmental protection, Pesticides and pests. Dated: June 5, 2006. Debra Edwards, Director, Special Review and Reregistration Division, Office of Pesticide Programs. [FR Doc. E6-8929 Filed 6-8-06; 8:45 am] BILLING CODE 6560-50-S ENVIRONMENTAL PROTECTION AGENCY [EPA-HQ-OPPT-2006-0488; FRL-8071-8] Certain New Chemicals; Receipt and Status Information AGENCY: Environmental Protection Agency (EPA). ACTION: Notice. SUMMARY: Section 5 of the Toxic Substances Control Act

(TSCA)requires any person who intends to manufacture (defined by statute to include import) a new chemical (i.e., a chemical not on the TSCA Inventory) to notify EPA and comply with the statutory provisions pertaining to the manufacture of new chemicals. Under sections 5(d)(2) and 5(d)(3) of TSCA, EPA is required to publish a notice of receipt of a premanufacture notice

(PMN)or an application for a test marketing exemption (TME), and to publish periodic status reports on the chemicals under review and the receipt of notices of commencement to manufacture those chemicals. This status report, which covers the period from May 1, 2006, to May 19, 2006, consists of the PMNs, pending or expired, and the notices of commencement to manufacture a new chemical that the Agency has received under TSCA section 5 during this time period. DATES: Comments identified by the specific PMN number or TME number, must be received on or before July 10, 2006. ADDRESSES: Submit your comments, identified by docket identification

(ID)no. EPA-HQ-OPPT-2006-0488, by one of the following methods. • *http://www.regulations.gov* . Follow the on-line instructions for submitting comments. • *Mail* : Document Control Office (7407M), Office of Pollution Prevention and Toxics (OPPT), Environmental Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460-0001. • *Hand Delivery* : OPPT Document Control Office (DCO, EPA East Bldg., Rm. 6428, 1201 Constitution Ave., NW., Washington, DC. Attention: Docket ID number EPA-HQ-OPPT-2006-0488. The DCO is open from 8 a.m. to 4 p.m., Monday through Friday, excluding legal holidays. The telephone number for the DCO is

(202)564-8930. Such deliveries are only accepted during the Docket's normal hours of operation, and special arrangements should be made for deliveries of boxed information. • *Instructions* : Direct your comments to docket ID number EPA-HQ-OPPT-2006-0488. EPA's policy is that all comments received will be included in the public docket without change and may be made available online at *http://www.regulations.gov* , including any personal information provided, unless the comment includes information claimed to be Confidential Business Information

(CBI)or other information whose disclosure is restricted by statute. Do not submit information that you consider to be CBI or otherwise protected through regulations.gov or e-mail. The regulations.gov website is an “anonymous access” systems, which means EPA will not know your identity or contact information unless you provide it in the body of your comment. If you send an e-mail comment directly to EPA without going through regulations.gov your e-mail address will be automatically captured and included as part of the comment that is placed in the public docket and made available on the Internet. If you submit an electronic comment, EPA recommends that you include your name and other contact information in the body of your comment and with any disk or CD ROM you submit. If EPA cannot read your comment due to technical difficulties and cannot contact you for clarification, EPA may not be able to consider your comment. Electronic files should avoid the use of special characters, any form of encryption, and be free of any defects or viruses. *Docket* : All documents in the docket are listed in the regulations.gov index. Although listed in the index, some information is not publicly available, i.e., CBI or other information whose disclosure is restricted by statute. Certain other material, such as copyrighted material, is not placed on the Internet and will be publicly available only in hard copy form. Publicly available docket materials are available electronically through regulations.gov or in hard copy at the OPPT Docket, EPA Docket Center (EPA/DC), EPA West, Room B102, 1301 Constitution Ave., NW., Washington, DC. The EPA Docket Center Public Reading Room is open from 8:30 a.m. to 4:30 p.m., Monday through Friday, excluding legal holidays. The telephone number for the Public Reading Room is

(202)566-1744, and the telephone number for the OPPT Docket is

(202)566-0280. FOR FURTHER INFORMATION CONTACT: Colby Lintner, Regulatory Coordinator, Environmental Assistance Division, Office of Pollution Prevention and Toxics (7408M), Environmental Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460-0001; telephone number:

(202)554-1404; e-mail address: *TSCA-Hotline@epa.gov* . SUPPLEMENTARY INFORMATION: I. General Information A. Does this Action Apply to Me? This action is directed to the public in general. As such, the Agency has not attempted to describe the specific entities that this action may apply to. Although others may be affected, this action applies directly to the submitter of the premanufacture notices addressed in the action. If you have any questions regarding the applicability of this action to a particular entity, consult the person listed under FOR FURTHER INFORMATION CONTACT . B. What Should I Consider as I Prepare My Comments for EPA? 1. *Submitting CBI* . Do not submit this information to EPA through regulations.gov or e-mail. Clearly mark the part or all of the information that you claim to be CBI. For CBI information in a disk or CD ROM that you mail to EPA, mark the outside of the disk or CD ROM as CBI and then identify electronically within the disk or CD ROM the specific information that is claimed CBI). In addition to one complete version of the comment that includes information claimed as CBI, a copy of the comment that does not contain the information claimed as CBI must be submitted for inclusion in the public docket. Information so marked will not be disclosed except in accordance with procedures set forth in 40 CFR part 2. 2. *Tips for preparing your comments* . When submitting comments, remember to: i. Identify the document by docket number and other identifying information (subject heading, **Federal Register** date and page number). ii. Follow directions - The agency may ask you to respond to specific questions or organize comments by referencing a Code of Federal Regulations

(CFR)part or section number. iii. Explain why you agree or disagree; suggest alternatives and substitute language for your requested changes. iv. Describe any assumptions and provide any technical information and/or data that you used. v. If you estimate potential costs or burdens, explain how you arrived at the estimate. vi. Provide specific examples to illustrate your concerns, and suggested alternatives. vii. Explain your views as clearly as possible, avoiding the use of profanity or personal threats. viii. Make sure to submit your comments by the comment period deadline identified. II. Why is EPA Taking this Action? Section 5 of TSCA requires any person who intends to manufacture (defined by statute to include import) a new chemical (i.e., a chemical not on the TSCA Inventory to notify EPA and comply with the statutory provisions pertaining to the manufacture of new chemicals. Under sections 5(d)(2) and 5(d)(3) of TSCA, EPA is required to publish a notice of receipt of a PMN or an application for a TME and to publish periodic status reports on the chemicals under review and the receipt of notices of commencement to manufacture those chemicals. This status report, which covers the period from May 1, 2006, to May 19, 2006, consists of the PMNs pending or expired, and the notices of commencement to manufacture a new chemical that the Agency has received under TSCA section 5 during this time period. III. Receipt and Status Report for PMNs This status report identifies the PMNs pending or expired, and the notices of commencement to manufacture a new chemical that the Agency has received under TSCA section 5 during this time period. If you are interested in information that is not included in the following tables, you may contact EPA as described in Unit II. to access additional non-CBI information that may be available. In Table I of this unit, EPA provides the following information (to the extent that such information is not claimed as CBI) on the PMNs received by EPA during this period: the EPA case number assigned to the PMN; the date the PMN was received by EPA; the projected end date for EPA's review of the PMN; the submitting manufacturer; the potential uses identified by the manufacturer in the PMN; and the chemical identity. **I. 71 Premanufacture Notices Received From: 05/01/06 to 05/19/06** Case No. Received Date Projected Notice End Date Manufacturer/Importer Use Chemical P-06-0465 05/01/06 07/29/06 Meadwestvaco Corporation

(S)Asphalt emulsifier salt

(G)Tall-oil fatty, alkylamino amides, hydrochloride P-06-0466 05/01/06 07/29/06 CBI

(G)Construction materials additive

(G)2-propenoic acid, 2-methyl-, methyl ester, polymer P-06-0467 05/01/06 07/29/06 CBI

(G)Blocked isocyanate

(G)Open, non-dispersive use. P-06-0468 05/02/06 07/30/06 CBI

(S)hardener for architectural coatings harener for metal primers for maintenance coatings

(G)Oxirane, (chloromethyl)-, polymer with .alpha.-hydro-.omega.-hydroxypoly[oxy(methyl-1,2-ethanediyl)] and methyloxirane polymer with oxirane 2-aminopropyl methyl ether P-06-0469 05/02/06 07/30/06 CBI

(S)Chlorinated polyester resin used in ultra violet curable inks and coatings

(G)Chlorinated polyester resin P-06-0470 05/02/06 07/30/06 Cognis Corporation

(S)Performance additive for hard surface cleaners

(S)1-propanaminium, *N,N,N* -trimethyl-3-[(2-methyl-1-oxo-2propenyl)-, chloride, polymer with *N* -(1-methylethyl)-2-propenamide, 2-methyl-2-[(1-oxo-2-propenyl) amino]-1-propanesulfonic acid, and 2-propenoic acid, Sodium salt P-06-0471 05/02/06 07/30/06 CBI

(G)Textile treatment additive

(G)Fluoroalkyl methacrylate copolymer P-06-0472 05/02/06 07/30/06 CBI

(G)Nonwoven internal additive

(G)Fluoroalkyl methacrylate copolymer P-06-0473 05/02/06 07/30/06 CBI

(G)Tile surface treatment

(G)Fluoroalkyl methacrylate copolymer P-06-0474 05/02/06 07/30/06 CBI

(G)Textile treatment additive

(G)Fluoroalkyl acrylate copolymer P-06-0475 05/02/06 07/30/06 CBI

(G)Textile treatment additive

(G)Fluoroalkyl acrylate copolymer P-06-0476 05/02/06 07/30/06 CBI

(G)Textile treatment additive

(G)Fluoroalkyl methacrylate copolymer P-06-0477 05/02/06 07/30/06 CBI

(G)Carpet treatment additive

(G)Fluoroalkyl methacrylate copolymer P-06-0478 05/02/06 07/30/06 CBI

(G)Carpet treatment additive

(G)Fluoroalkyl acrylate copolymer P-06-0479 05/02/06 07/30/06 CBI

(G)Carpet treatment additive

(G)Fluoroalkyl acrylate copolymer P-06-0480 05/02/06 07/30/06 CBI

(G)Textile treatment additive

(G)Fluoroalkyl acrylate copolymer P-06-0481 05/02/06 07/30/06 CBI

(G)Paper treatment additive

(G)Fluoroalkyl acrylate copolymer P-06-0482 05/02/06 07/30/06 CBI

(G)Textile treatment additive

(G)Fluoroalkyl acrylate copolymer P-06-0483 05/02/06 07/30/06 CBI

(G)Paper treatment additive

(G)Fluoroalkyl methacrylate copolymer P-06-0484 05/02/06 07/30/06 CBI

(G)Textile treatment additive

(G)Fluoroalkyl methacrylate copolymer P-06-0485 05/02/06 07/30/06 CBI

(G)texile treatment additive

(G)Fluoroalkyl methacrylate copolymer P-06-0486 05/02/06 07/30/06 CBI

(G)Paper treatment additive

(G)Fluoroalkyl methacrylate copolymer P-06-0487 05/02/06 07/30/06 CBI

(G)monomer for textile and paper treatment additive

(G)Fluoroalkyl acrylate P-06-0488 05/02/06 07/30/06 CBI

(G)Textile treatment additive

(G)Fluoroalkyl methacrylate copolymer P-06-0489 05/02/06 07/30/06 CBI

(G)textile treatment additive

(G)Fluoroalkyl methacrylate copolymer P-06-0490 05/02/06 07/30/06 CBI

(G)Textile treatment additive

(G)Fluoroalkyl methacrylate copolymer P-06-0491 05/02/06 07/30/06 CBI

(G)textile treatment additive

(G)Fluoroalkyl methacrylate copolymer P-06-0492 05/02/06 07/30/06 CBI

(G)Textile treatment additive

(G)Fluoroalkyl acrylate copolymer P-06-0493 05/02/06 07/30/06 CBI

(G)Textile treatment additive

(G)Fluoroalkyl methacrylate copolymer P-06-0494 05/02/06 07/30/06 CBI

(G)Textile treatment additive

(G)Fluoroalkyl methacrylate copolymer P-06-0495 05/02/06 07/30/06 CBI

(G)Carpet treatment additive

(G)Fluorochemical urethane P-06-0496 05/02/06 07/30/06 CBI

(G)Carpet treatment additive

(G)Fluoroalkyl acrylate copolymer P-06-0497 05/02/06 07/30/06 CBI

(G)Textile treatment additive

(G)Fluoroalkyl acrylate copolymer P-06-0498 05/02/06 07/30/06 CBI

(G)Carpet treatment additive

(G)Fluoroalkyl methacrylate copolymer P-06-0499 05/02/06 07/30/06 CBI

(G)Nonwoven internal additive

(G)Fluoroalkyl acrylate copolymer P-06-0500 05/02/06 07/30/06 CBI

(G)Textile treatment additive

(G)Fluoroalkyl methacrylate copolymer P-06-0501 05/02/06 07/30/06 CBI

(G)Textile treatment additive

(G)Fluoroalkyl methacrylate copolymer P-06-0502 05/02/06 07/30/06 CBI

(G)Textile treatment additive

(G)Fluoroalkyl methacrylate copolymer P-06-0503 05/02/06 07/30/06 CBI

(G)Textile treatment additive

(G)Fluoroalkylacrylate copolymer P-06-0504 05/02/06 07/30/06 CBI

(G)Carpet treatment additive

(G)Fluoroalkyl acrylate copolymer P-06-0505 05/02/06 07/30/06 CBI

(G)Textile treatment additive

(G)Fluoroalkyl methacrylate copolymer P-06-0506 05/02/06 07/30/06 CBI

(G)Nonwoven internal additive

(G)Fluoroalkyl methacrylate copolymer P-06-0507 05/02/06 07/30/06 CBI

(G)Paper treatment additive

(G)Fluoroalkyl acrylate copolymer P-06-0508 05/02/06 07/30/06 CBI

(G)Textile treatment additive

(G)Fluoroalkylacrylate copolymer P-06-0509 05/03/06 07/31/06 CBI

(G)Solvent in fuel production; solvent in industrial plants

(G)Substituted alkanol P-06-0510 05/04/06 08/01/06 CBI

(G)Additive, open, non-dispersive use

(G)Polyether modified polydimethylsiloxane P-06-0511 05/04/06 08/01/06 CBI

(G)Additive, open, non-dispersive use

(G)Polyether modified polydimethylsiloxane P-06-0512 05/04/06 08/01/06 CBI

(G)Component in polyurethane adhesive/sealant.

(G)Polyurethane prepolymer with a polycarbonatediol P-06-0513 05/04/06 08/01/06 CBI

(G)Metal refining intermediate

(S)Tantalum, fluoro hydrogen complexes P-06-0514 05/05/06 08/02/06 CBI

(G)Chemical intermediate

(G)Al, mixed metal and alcohol complex P-06-0515 05/08/06 08/05/06 CBI

(G)Paper strength additive

(G)Glyoxalated acrylamide, dadmac, 2-hydroxyethylacrylate ternary copolymer P-06-0516 05/08/06 08/05/06 CBI

(G)Paper strength additive

(G)Glyoxalated branched acrylamide, dadmac, 2-hydroxyethylacrylate ternary copolymer P-06-0517 05/08/06 08/05/06 CBI

(G)Catalyst

(S)Neodymium, tris[bis(2-ethylhexyl)phosphato-.kappa.o′′,-.kappa.o′′′]]- P-06-0518 05/08/06 08/05/06 IGM Resins Inc.

(G)Ultra violet initiator

(S)Idodium, bis(4-methylphenyl)-, hexafluorophosphate(1-) P-06-0519 05/09/06 08/06/06 CBI

(G)Pigment additive; open, non-dispersive use

(G).beta.-alanine[(substituted-pyrrole-diyl)bis[(substituted)bis, aluminium salt (3:2) P-06-0520 05/09/06 08/06/06 CBI

(G)Pigment additive; open, non-dispersive use

(G)[biphenyl]-sulfonamide],-((substituted)pyrrole-diyl)bis[(substituted)propyl- P-06-0521 05/08/06 08/05/06 CBI

(G)Paper strength additive

(G)Acrylamide, dadmac, 2-hydroxyethylacrylate ternary copolymer P-06-0522 05/08/06 08/05/06 CBI

(G)Paper strength additive

(G)Branched acrylamide, dadmac, 2-hydroxyethylacrylate ternary copolymer P-06-0523 05/09/06 08/06/06 CBI

(G)Prepolymer of polyester urethane

(G)Aromatic saturated copolyester P-06-0524 05/15/06 08/12/06 Huntsman Corporation

(S)Intermediate for liquid soap component; intermediate for surfactant

(S)Propanesulfonic acid, 1(or 2)-hydroxy-, monosodium salt P-06-0525 05/15/06 08/12/06 Huntsman Corporation

(S)Liquid soap

(S)Octadecanoic acid, methyl-2-sulfoethyl ester, sodium salt P-06-0526 05/15/06 08/12/06 Huntsman Corporation

(S)Liquid soap

(S)9-octadecanoic acid, (9 *z* )-, methyl-2-sulfoethyl ester, sodium salt P-06-0527 05/15/06 08/12/06 Huntsman Corporation

(S)Liquid soap

(S)Fatty acids, C 8-18 and C 18 -unsaturated, methyl-2-sulfoethyl esters, sodium salt P-06-0528 05/15/06 08/12/06 Huntsman Corporation

(S)Liquid soap

(S)Fatty acids, coco, hydrogenated, methyl-2-sulfoethyl ester, sodium salt P-06-0529 05/15/06 08/12/06 Huntsman Corporation

(S)Liquid soap

(S)Fatty acids, coco, heavy fractions, methyl-2-sulfoethyl esters, sodium salts P-06-0530 05/11/06 08/08/06 Septon Company of America

(S)Adhesives; lubricant; emulsion

(S)2,5-furandione, polymer with 2-methyl-1-propene, amide imide P-06-0531 05/15/06 08/12/06 Oleon Americas, Inc.

(G)Lubricant base oil

(S)Fatty acids, coco, esters P-06-0532 05/17/06 08/14/06 CBI

(G)Coating component

(G)Substituted styrene acrylate copolymer P-06-0533 05/17/06 08/14/06 CBI

(G)Binder resin

(G)“Carbomonocycledicarboxylic acid, polymer with alkenedioic acid, 1,3-dihydro-1,3-dioxo-5-isobenzofurancarboxylic acid, dihydro-3-(tetrapropenyl)-2,5-furandione, .alpha.,.alpha.′-[(1-methylethylidene)dicarbomonocycle]bis[.omega.-hydro xypoly(oxy-1,2-ethanediyl)] and .alpha., .alpha.′-[(1-methylethylidene)dicarbomonocycle]bis[.omega.-hydroxypoly[oxy(methyl-1,2-ethanediyl)]]” P-06-0534 05/17/06 08/14/06 CBI

(S)Base resin for ultraviolet light and electron beam curable formulations

(G)Oxirane based polymer with 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylycylohexane, 2-hydroxyethyl acrylate-blocked P-06-0535 05/19/06 08/16/06 BASF Corporation

(G)Automotive application

(G)Ester urethane In Table II of this unit, EPA provides the following information (to the extent that such information is not claimed as CBI) on the Notices of Commencement to manufacture received: **II. 26 Notices of Commencement From: 05/01/06 to 05/19/06** Case No. Received Date Commencement Notice End Date Chemical P-02-0256 05/01/06 04/25/06

(G)Polyester polyether isocyanate P-03-0591 05/01/06 03/23/06

(G)Water dispersable polyurethane polymer P-04-0289 05/17/06 04/21/06

(G)Ethylene - tetrafluoroethylene copolymer P-04-0291 05/16/06 05/03/06

(G)Isocyanate functional polyester urethane polymer P-04-0422 05/02/06 04/21/06

(G)Tetraalkyl indone P-04-0536 05/16/06 04/20/06

(G)Polyurethane P-04-0636 05/04/06 04/22/06

(G)Cuprate, [[[[[[[(sulfonaphthalenyl)]azo]-(substitutedphenyl)]azo]-(substitutedsulfonaphthalenyl)]azo]-substitutedphenyl-substituted heteromonocycle], sodium salts P-04-0721 05/12/06 05/08/06

(G)Polysiloxane, aminoalkyl terminated polymers with urea functionality alkylcyclohexane P-04-0844 05/15/06 04/20/06

(G)Polyalkylene phthalocyanine P-04-0888 05/10/06 04/12/06

(G)Dynacoll 7130 P-04-0950 05/09/06 05/01/06

(G)Reaction product of substituted naphthalenesulfonic acid azo substituted phenyl amino substituted triazine compound and substituted phenyl azo substituted naphthalenesulfonic acid P-05-0439 05/05/06 03/10/06

(G)Acetate polymer with unsaturated alkane and alkenol, cyclic acetal with aldehyde P-05-0508 05/08/06 04/10/06

(S)Neodecanoic acid, oxiranylmethyl ester, polymer with 1,4-cyclohexanedimethanol, 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane and methyloxirane polymer with oxirane 2-aminopropyl methyl ether P-05-0585 05/08/06 04/10/06

(S)2-propenoic acid, 2-methyl-, polymer with butyl 2-methyl-2-propenoate, 1,1-dimethylethyl 2-methyl-2-propenoate and 2-hydroxyethyl 2-methyl-2-propenoate, tert-bu peroxide-initiated P-05-0673 05/11/06 05/03/06

(G)Siloxane coated silica nanoparticles P-06-0029 05/02/06 04/19/06

(G)Amine modified monomer acrylate P-06-0105 05/17/06 04/25/06

(S)Coke(coal tar), low-temp., low-temp. gasification pitch, calcined P-06-0120 05/09/06 04/18/06

(G)Naphthalenedisulfonic acid salt P-06-0156 04/28/06 04/14/06

(S)Silane, ethenyltrimethoxy-, reaction products with 1-butene-ethylene-propene polymer P-06-0228 05/15/06 04/11/06

(G)Alkylcarbosilane polymer P-06-0235 05/15/06 04/11/06

(G)Product 1: alkoxylated chloro-substituted alkylchlorosilane, chloro-substituted alkyl alkoxysilane P-06-0236 05/15/06 04/11/06

(G)Product 2: alkoxylated chloro-substituted alkylchlorosilane, chloro-substituted alkyl alkoxysilane P-06-0251 05/17/06 05/04/06

(G)Sodium salt of the copolymer of acrylic acid. methyl methacrylate, *p* -sulfophenymethallylether, sodium salt, sodium methallylsulfonate, 2-acrylamido-2-methylpropane sulfonic acid sodium salt P-06-0270 05/16/06 05/10/06

(S)Fatty acids, C 16-18 , isononyl esters P-93-1700 05/15/06 05/05/06

(G)Polyester polyol isocyanate polymer P-99-0858 05/09/06 05/01/06

(G)Polyester polyether isocyanate polymer List of Subjects Environmental protection, Chemicals, Premanufacturer notices. Dated: May 31, 2006. LaRona M. Washington, Acting Director, Information Management Division, Office of Pollution Prevention and Toxics. [FR Doc. E6-8931 Filed 6-8-06; 8:45 am] BILLING CODE 6560-50-S FEDERAL RESERVE SYSTEM Formations of, Acquisitions by, and Mergers of Bank Holding Companies The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 *et seq.* ) (BHC Act), Regulation Y (12 CFR part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The applications listed below, as well as other related filings required by the Board, are available for immediate inspection at the Federal Reserve Bank indicated. The application also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, nonbanking activities will be conducted throughout the United States. Additional information on all bank holding companies may be obtained from the National Information Center Web site at *http://www.ffiec.gov/nic/* . Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than July 6, 2006. **A. Federal Reserve Bank of Atlanta** (Andre Anderson, Vice President) 1000 Peachtree Street, NE., Atlanta, Georgia 30309: *1. Riverside Banking Company* , Fort Pierce, Florida; to merge with First Community Bank Holding Corporation, and thereby indirectly acquire voting shares of its subsidiary, First Community Bank, both of Debary, Florida. **B. Federal Reserve Bank of Minneapolis** (Jacqueline G. King, Community Affairs Officer) 90 Hennepin Avenue, Minneapolis, Minnesota 55480-0291: *1. Hunter Holding Company* , Hunter, North Dakota; to merge with Streeter Insurance Agency, Inc., Streeter, North Dakota, and thereby indirectly acquire State Bank of Streeter, Streeter, North Dakota. In connection with this application, Applicant also has applied to acquire and merge with Streeter Insurance Agency, Inc., Streeter, North Carolina, and thereby engage in insurance agency activities in a town with a population not exceeding 5,000, pursuant to section 225.28(b)(11)(iii)(A) of the Board's Regulation Y. Board of Governors of the Federal Reserve System, June 6, 2006. Robert deV. Frierson, Deputy Secretary of the Board. [FR Doc. E6-9013 Filed 6-8-06; 8:45 am] BILLING CODE 6210-01-S FEDERAL RESERVE SYSTEM Consumer Advisory Council ACTION: Notice of Meeting of Consumer Advisory Council The Consumer Advisory Council will meet on Thursday, June 22, 2006. The meeting, which will be open to public observation, will take place at the Federal Reserve Board's offices in Washington, DC, in Dining Room E on the Terrace level of the Martin Building. Anyone planning to attend the meeting should, for security purposes, register no later than Tuesday, June 20, by completing the form found online at: https://www.federalreserve.gov/secure/forms/cacregistration.cfm Additionally, attendees must present photo identification to enter the building. The meeting will begin at 9 a.m. EDT and is expected to conclude at 1 p.m. The Martin Building is located on C Street, NW., between 20th and 21st Streets. The Council's function is to advise the Board on the exercise of the Board's responsibilities under various consumer financial services laws and on other matters on which the Board seeks its advice. Time permitting, the Council will discuss the following topics: Home Equity Lending • Assessing the impact of the rules implementing the Home Ownership and Equity Protection Act (HOEPA) • Issues related to the subprime mortgage market • Nontraditional mortgage products Financial Literacy • Issues related to the goals for and the effectiveness of financial literacy programs. Reports by committees and other matters initiated by Council members also may be discussed. Persons wishing to submit views to the Council on any of the above topics may do so by sending written statements to Kyan Bishop, Secretary of the Consumer Advisory Council, Division of Consumer and Community Affairs, Board of Governors of the Federal Reserve System, Washington, DC 20551. Information about this meeting may be obtained from Ms. Bishop, 202-452-6470. Board of Governors of the Federal Reserve System, June 6, 2006. Jennifer J. Johnson Secretary of the Board. [FR Doc. E6-8977 Filed 6-8-06; 8:45 am] BILLING CODE 6210-01-S GENERAL SERVICES ADMINISTRATION [OMB Control No. 3090-0228] Office of Civil Rights; Information Collection; Nondiscrimination in Federal Financial Assistance Programs AGENCY: Office of Civil Rights, GSA. ACTION: Notice of request for comments regarding a renewal to an existing OMB clearance. SUMMARY: Under the provisions of the Paperwork Reduction Act of 1995 (44 U.S.C. Chapter 35), the General Services Administration has submitted to the Office of Management and Budget

(OMB)a request to review and approve an extension of a currently approved information collection requirement regarding regarding nondiscrimination in Federal financial assistance programs. A request for public comments was published at 71 FR 10687, March 2, 2006. No comments were received. This OMB clearance expires on June 30, 2006. This information is needed to facilitate nondiscrimination in GSA's Federal Financial Assistance Programs, consistent with Federal civil rights laws and regulations that apply to recipients of Federal financial assistance. Public comments are particularly invited on: Whether this collection of information is necessary and whether it will have practical utility; whether our estimate of the public burden of this collection of information is accurate, and based on valid assumptions and methodology; ways to enhance the quality, utility, and clarity of the information to be collected. DATES: Submit comments on or before: July 10, 2006. ADDRESSES: Submit comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Ms. Hillary Jaffe, GSA Desk Officer, OMB, Room 10236, NEOB, Washington, DC 20503, and a copy to the Regulatory Secretariat (VIR), General Services Administration, Room 4035, 1800 F Street, NW., Washington, DC 20405. Please cite OMB Control No. 3090-0228, Nondiscrimination in Federal Financial Assistance Programs, in all correspondence. FOR FURTHER INFORMATION CONTACT: Evelyn Britton, Compliance Officer, Office of Civil Rights, at telephone

(202)501-4347 or via e-mail to *evelyn.britton@gsa.gov* . SUPPLEMENTARY INFORMATION: A. Purpose The General Services Administration

(GSA)has mission responsibilities related to monitoring and enforcing compliance with Federal civil rights laws and regulations that apply to Federal Financial Assistance programs administered by GSA. Specifically, those laws provide that no person on the ground of race, color, national origin, disability, sex or age shall be excluded from participation in, be denied the benefits of, or be otherwise subjected to discrimination under any program in connection with which Federal financial assistance is extended under laws administered in whole or in part by GSA. These mission responsibilities generate the requirement to request and obtain certain data from recipients of Federal surplus property for the purpose of determining compliance, such as the number of individuals, based on race and ethnic origin, of the recipient's eligible and actual serviced population; race and national origin of those denied participation in the recipient's program(s); non-English languages encountered by the recipient's program(s) and how the recipient is addressing meaningful access for individuals that are Limited English Proficient; whether there has been complaints or lawsuits filed against the recipient based on prohibited discrimination and whether there has been any findings; and whether the recipient's facilities are accessible to qualified individuals with disabilities. B. Annual Reporting Burden *Respondents:* 200. *Responses Per Respondent:* 1. *Total Responses:* 200. *Hours Per Response:* 2. *Total Burden Hours:* 400. *Obtaining Copies of Proposals:* Requesters may obtain a copy of the information collection documents from the General Services Administration, Regulatory Secretariat (VIR), 1800 F Street, NW., Room 4035, Washington, DC 20405, telephone

(202)208-7312. Please cite OMB Control No. 3090-0228, Nondiscrimination in Federal Financial Assistance Programs, in all correspondence. Dated: May 31, 2006 Michael W. Carleton, Chief Information Officer. [FR Doc. E6-8999 Filed 6-8-06; 8:45 am] BILLING CODE 6820-34-S DEPARTMENT OF HEALTH AND HUMAN SERVICES Assistant Secretary for Planning & Evaluation Medicaid Program; Meeting of the Medicaid Commission AGENCY: Assistant Secretary for Planning & Evaluation (ASPE), HHS. ACTION: Notice of meeting. SUMMARY: This notice announces a public meeting of the Medicaid Commission. Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. App. 2, 10(a)(1) and (a)(2)). The Medicaid Commission will advise the Secretary on ways to modernize the Medicaid program so that it can provide high-quality health care to its beneficiaries in a financially sustainable way. DATES: *The Meeting:* July 11-12, 2006. The meeting will begin at 9 a.m. on July 11, and 8:30 a.m. on July 12. *Special Accommodations:* Persons attending the meeting who are hearing or visually impaired, or have a condition that requires special assistance or accommodations, are asked to notify the Medicaid Commission by June 30, 2006 (see FOR FURTHER INFORMATION CONTACT ). ADDRESSES: *The Meeting:* The meeting will be held at the following address: Sheraton Crystal City, 1800 Jefferson Davis Highway, Arlington, Virginia 22202, United States, telephone:

(703)486-1111, fax:

(703)769-3970. *Web site:* You may access up-to-date information on the Medicaid Commission at *http://aspe.hhs.gov/medicaid/.* FOR FURTHER INFORMATION CONTACT: Margaret Reiser,

(202)205-8255. SUPPLEMENTARY INFORMATION: On May 24, 2005, we published a notice (70 FR 29765) announcing the Medicaid Commission and requesting nominations for individuals to serve on the Medicaid Commission. This notice announces a public meeting of the Medicaid Commission. Topics of the Meeting The Commission will discuss options for making longer-term recommendations on the future of the Medicaid program that ensure long-term sustainability. Issues to be addressed may include, but are not limited to: Eligibility, benefit design, and delivery; expanding the number of people covered with quality care while recognizing budget constraints; long term care; quality of care, choice, and beneficiary satisfaction; and program administration. Procedure and Agenda This meeting is open to the public. There will be a public comment period at the meeting. The Commission may limit the number and duration of oral presentations to the time available. We will request that you declare at the meeting whether or not you have any financial involvement related to any services being discussed. After the presentations and public comment period, the Commission will deliberate openly. Interested persons may observe the deliberations, but the Commission will not hear further comments during this time except at the request of the Chairperson. The Commission will also allow an open public session for any attendee to address issues specific to the topic. Authority: 5 U.S.C. App. 2, 10(a)(1) and (a)(2). Dated: June 2, 2006. Donald A. Young, Acting Assistant Secretary for Planning and Evaluation, Department of Health and Human Services. [FR Doc. E6-8993 Filed 6-8-06; 8:45 am] BILLING CODE 5150-05-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Targeted Evaluation of the President's Emergency Plan for AIDS Relief (PEPFAR) Funded Prevention of Mother-to-Child HIV Transmission (PMTCT), and Adherence to Antiretroviral Therapy

(ART)Programs, Contract Solicitation Numbers

(CSN)2006-N-08428, 2006-N-08429, and 2006-N-08430 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention

(CDC)announces the following meeting: *Name:* Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Targeted Evaluation of the President's Emergency Plan for AIDS Relief (PEPFAR) Funded Prevention of Mother-to-Child HIV Transmission (PMTCT), and Adherence to Antiretroviral Therapy

(ART)Programs, Contract Solicitation Numbers

(CSN)2006-N-08428, 2006-N-08429, and 2006-N-08430. *Time and Date:* 8:30 a.m.-9 a.m., June 27, 2006 (Open). 9 a.m.-6 p.m., June 27, 2006 (Closed). *Place:* Renaissance Concourse Hotel—Marriott, One Hartsfield Center Parkway, Atlanta, GA 30354, Telephone 404-209-9999. *Status:* The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)

(4)and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463. *Matters to be Discussed:* The meeting will include the review, discussion, and evaluation of applications received in response to “Targeted Evaluation of the PEPFAR Funded PMTCT, and ART Programs,” Contract Solicitation Numbers

(CSN)2006-N-08428, 2006-N-08429, and 2006-N-08430. *For Further Information Contact:* Amy L. Sandul, Health Scientist, National Center for HIV, STD, and Tuberculosis Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS E-41, Atlanta, GA 30333, Telephone 404.639.6485. The Director, Management Analysis and Services Office, has been delegated the authority to sign **Federal Register** notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: June 2, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6-8991 Filed 6-8-06; 8:45 am] BILLING CODE 4163-18-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Committee on Immunization Practices: Meeting In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention

(CDC)announces the following Federal Committee meeting. *Name:* Advisory Committee on Immunization Practices (ACIP). *Time and Date:* 8 a.m.-6 p.m., June 29, 2006. 8 a.m.-4 p.m., June 30, 2006. *Place:* Centers for Disease Control and Prevention, 1600 Clifton Road, NE., Building 19, Room 232, Atlanta, Georgia 30333. *Status:* Open to the public, limited only by the space available. *Purpose:* The Committee is charged with advising the Director, CDC, on the appropriate uses of immunizing agents. In addition, under 42 U.S.C. 1396s, the Committee is mandated to establish and periodically review and, as appropriate, revise the list of vaccines for administration to vaccine-eligible children through the Vaccines for Children

(VFC)program, along with schedules regarding the appropriate periodicity, dosage, and contraindications applicable to the vaccines. *Matters to be Discussed:* The agenda will include discussions on Human Papillomavirus Vaccine, which will include a VFC Vote; Varicella Virus Vaccine, which will include a VFC Vote; Influenza Vaccine; Mumps Outbreak; Use of Tdap in pregnant women; Adult Immunization Schedule; Pneumococcal Vaccine; Herpes zoster (Shingles) Vaccine; Childhood/Adolescent Immunization Schedule; Immunization Safety; Menactra Supply and Prioritization; Update on Rotavirus Vaccine; and Agency updates. Agenda items are subject to change as priorities dictate. *For Further Information Contact:* Demetria Gardner, Epidemiology and Surveillance Division, National Immunization Program, CDC, 1600 Clifton Road, NE., (E-61), Atlanta, Georgia 30333, telephone 404/639-8096, fax 404/639-8616. The Director, Management Analysis and Services Office, has been delegated the authority to sign **Federal Register** notices pertaining to announcements of meetings and other committee management activities for both the CDC and ATSDR. Dated: June 2, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6-8994 Filed 6-8-06; 8:45 am] BILLING CODE 4163-18-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare and Medicaid Services [Document Identifier: CMS-10195] Emergency Clearance: Public Information Collection Requirements Submitted to the Office of Management and Budget

(OMB)AGENCY: Center for Medicare and Medicaid Services. In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Centers for Medicare and Medicaid Services (CMS), Department of Health and Human Services, is publishing the following summary of proposed collections for public comment. Interested persons are invited to send comments regarding this burden estimate or any other aspect of this collection of information, including any of the following subjects:

(1)The necessity and utility of the proposed information collection for the proper performance of the agency's functions;

(2)the accuracy of the estimated burden;

(3)ways to enhance the quality, utility, and clarity of the information to be collected; and

(4)the use of automated collection techniques or other forms of information technology to minimize the information collection burden. We are, however, requesting an emergency review of the information collection referenced below. In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, we have submitted to the Office of Management and Budget

(OMB)the following requirements for emergency review. We are requesting an emergency review because the collection of this information is needed before the expiration of the normal time limits under OMB's regulations at 5 CFR part 1320. This is necessary to ensure compliance with an initiative of the Administration. We cannot reasonably comply with the normal clearance procedures because of an unanticipated event. The purpose of the Medicare Recovery Audit Contractor

(RAC)Demonstration Project is to evaluate the cost and savings to the Medicare program and to make appropriate recommendations to Congress on the cost-effectiveness of extending or expanding the project. Because RACs have been used successfully in non-Medicare markets, The Centers for Medicare and Medicaid Services

(CMS)is conducting this demonstration project to test new techniques for identifying and collecting overpayments. This is a request for OMB approval of a Provider Satisfaction Survey to assess the impact of Medicare Recovery Audit Contractors

(RACs)on the provider community. The Centers for Medicare and Medicaid Services

(CMS)has contracted with Econometrica, Inc. to conduct an independent evaluation of the Medicare RAC demonstration. The results, which will be summarized in a report to Congress, will be used to assess the financial impact of the demonstration on the Medicare program and to make recommendations for the demonstration's extension or expansion. Previous research by the U.S. Government Accountability Office found that RACs have the potential to burden private providers. The purpose of this study is to determine whether RACs can perform effectively with a low risk of burden and friction with healthcare providers. 1. *Type of Information Collection Request:* New collection; *Title of Information Collection:* Evaluation of Medicare Recovery Audit Contractor

(RAC)Demonstration Provider Satisfaction Survey; *Use:* The purpose of the RAC Provider Satisfaction Survey is to gauge provider communications and satisfaction with the RACs. Measuring providers' reactions to and experiences with RACs will enable CMS better understand the potential impact of the RACs on providers nationwide and to improve and refine the process, both in the context of the current demonstration as well as in future reform initiatives. The survey will cover all aspects of provider transactions with RACs. *Form Number:* CMS-10195 (OMB#: 0938-NEW); *Frequency:* Reporting—One-time; *Affected Public:* Business or other for-profit; *Number of Respondents:* 1,200; *Total Annual Responses:* 1,200; *Total Annual Hours:* 276. CMS is requesting OMB review and approval of this collection by *July 7, 2006,* with a 180-day approval period. Written comments and recommendation will be considered from the public if received by the individuals designated below by July 3, 2006. To obtain copies of the supporting statement and any related forms for the proposed paperwork collections referenced above, access CMS' Web site address at *http://www.cms.hhs.gov/regulations/pra* or E-mail your request, including your address, phone number, OMB number, and CMS document identifier, to *Paperwork@cms.hhs.gov,* or call the Reports Clearance Office on

(410)786-1326. Interested persons are invited to send comments regarding the burden or any other aspect of these collections of information requirements. However, as noted above, comments on these information collection and recordkeeping requirements must be mailed and/or faxed to the designees referenced below by July 3, 2006: CMS, Office of Strategic Operations and Regulatory Affairs, Division of Regulations Development—B, Attn: William N. Parham, III, Room C4-26-05, 7500 Security Boulevard, Baltimore, MD 21244-1850, and OMB Human Resources and Housing Branch, Attention: Carolyn Lovett, New Executive Office Building, Room 10235, Washington, DC 20503. Fax Number:

(202)395-6974. Dated: May 26, 2006. Michelle Shortt, Director, Regulations Development Group, Office of Strategic Operations and Regulatory Affairs. [FR Doc. 06-5134 Filed 6-1-06; 2:37 pm]

Connectionstraces to 4

Traces to 4 documents

U.S. Code

4 references not yet in our index